当前位置: 首页 > 期刊 > 《中国实用医药》 > 2012年第35期 > 正文
编号:12335974
139例肺腺鳞癌的预后因素分析(3)
http://www.100md.com 2012年12月15日 刘智华 潘纯国 徐建华 钟军
第1页

    参见附件。

     [12] Douillard J,Rosell R, Delena M, et alANITA:Phase III adjuvant vinorelbine(N)and cisplatin(P)versus observation(OBS) in completely resected(stage) nonsmall cell lung cancer(NSCLC)patientsJ Clin Oncol,2005,23(suppl16):S624.

    [13] Cooke DT, Nguyen DV, Yang Y, et al Survival comparison of adenosquamous, squamous cell, and adenocarcinoma of the lung after lobectomy Ann Thorac Surg, 2010,90(3):943948.

    [14] Bastide K, Ugolin N, Levalois C, et al Are adenosquamous lung carcinomas a simple mix of adenocarcinomas and squamous cell carcinomas, or more complex at the molecular level? Lung Cancer,2010,68(1):19.

    [15] Tochigi N, Dacic S, Nikiforova M,et alAdenosquamous carcinoma of the lung:a microdissection study of KRAS and EGFR mutational and amplification status in a western patient population Am J Clin Pathol, 2011,135(5):783789.

    [16] Kang SM, Kang HJ, Shin JH,et alIdentical epidermal growth factor receptor mutations in adenocarcinomatous and squamous cell carcinomatous components of adenosquamous carcinoma of the lung Cancer,2007,109(3):581587.

    

您现在查看是摘要介绍页,详见PDF附件(3296kb)